Related Experiment Video
Updated: Aug 20, 2025

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
Published on: July 20, 2022
Risk of Inappropriately Timed Live Vaccination After Pediatric Cardiovascular Surgery
Abigail N Shockley1, Emily N Israel2,3, Christopher A Thomas4
1Department of Clinical Pharmacy (ANS), MD Anderson Cancer Center, Houston, TX.
Insights
Infants undergoing cardiac surgery often receive live vaccines too early after blood transfusions, risking reduced efficacy. This study found 67% of young children were inappropriately vaccinated post-cardiac surgery and blood product transfusion.
Area of Science:
- Pediatric cardiology
- Immunology
- Vaccinology
Background:
- Live vaccine administration timing is critical for efficacy, with recommendations to delay post-blood product transfusion.
- Infants aged 5-12 months undergoing cardiac surgery requiring blood products may face vaccination schedule disruptions.
- Current guidelines from the American Academy of Pediatrics (AAP), Advisory Committee on Immunization Practices (ACIP), and Centers for Disease Control and Prevention (CDC) advise specific delays.
Purpose of the Study:
- To determine the risk of inappropriate live vaccination timing in pediatric patients post-cardiovascular surgery.
- To assess the incidence of live vaccine administration within recommended delay periods after receiving blood products.
Main Methods:
- Retrospective chart review of 345 pediatric patients (5-12 months old) undergoing cardiovascular surgery.
- Analysis included patients who received packed red blood cells (PRBCs) and/or platelets during admission.
- Primary endpoint: incidence of live vaccine administration within 7 months of PRBCs/platelets.
Main Results:
- 67% (n=230) of the 345 included patients received live vaccines inappropriately after transfusion.
- A significant proportion of pediatric cardiac surgery patients experienced non-compliance with vaccination guidelines.
Conclusions:
- Infants undergoing cardiac surgery (5-12 months) are at high risk for improper live vaccine timing.
- A substantial percentage of these children received live vaccines inconsistently with AAP, ACIP, and CDC recommendations.
- Provider and patient education may be necessary to improve vaccination practices.
Objective:
The American Academy of Pediatrics (AAP), Advisory Committee on Immunization Practices (ACIP), and Centers for Disease Control and Prevention (CDC) recommend delaying live vaccinations up to 11 months after transfusions of certain blood products due to the risk of immunoglobulins decreasing immunization efficacy. Because vaccination schedules recommend live immunizations at 12 months, infants aged 5 to 12 months who undergo cardiac surgery requiring blood products are potentially at risk for improper vaccination. The objective of this study was to identify the risk of inappropriately timed live vaccination in pediatric patients after cardiovascular surgery.
Methods:
This single-center, retrospective chart review included 345 patients 5 to 12 months of age who underwent cardiovascular surgery between January 1, 2010, and December 31, 2016. Included patients received packed red blood cells (PRBCs) and/or platelets during the surgical admission and a live vaccine within the first 18 months of life. The primary endpoint was the incidence of live vaccine administration within 7 months of receiving PRBCs and/or platelets.
Results:
Of the 345 included patients, 67% (n = 230) were inappropriately vaccinated after receiving platelets and/or PRBCs during cardiac surgery.
Conclusions:
Infants who undergo cardiac surgery between the ages of 5 and 12 months are at risk for inappropriate live vaccination timing. A clinically significant percentage of pediatric patients who received blood products during a cardiac surgical admission later received live vaccines at times that were inconsistent with AAP, ACIP, and CDC recommendations. Future interventions aimed at educating providers and patients may be warranted.
Related Concept Videos
Cardiac Catheterization IV: Nursing Management
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiac Catheterization I: Pre-Procedure Overview
Cardiopulmonary Resuscitation IV: Pharmacological Management
Aneurysm IV: Nursing Management
Aortic Regurgitation IV: Nursing Management

